Table 1.
MCI | p | SCI | p | AD | |
---|---|---|---|---|---|
Age, years | 64.2 | <0.001 | 57.8 | <0.001 | 70.1 |
Female | 53.9 | 0.003 | 64.2 | 0.893 | 63.6 |
Years of education | 12.0 | <0.001 | 13.3 | <0.001 | 10.9 |
Symptom duration, years | 3.5 | 0.390 | 3.3 | 0.074 | 2.9 |
Family history of dementia | 34.0 | <0.001 | 48.6 | 0.004 | 36.1 |
Hyperlipidemia | 29.8 | <0.001 | 18.3 | 0.008 | 27.8 |
Diabetes | 13.4 | <0.001 | 5.3 | 0.122 | 8.6 |
Hypertension | 42.2 | <0.001 | 25.2 | <0.001 | 46.2 |
Heart disease | 19.6 | <0.001 | 7.8 | <0.001 | 19.2 |
Stroke/TIA | 39.4 | 0.057 | 23.8 | 0.682 | 28.0 |
Parkinsonism | 21.1 | 0.018 | 5.6 | 0.925 | 5.0 |
Allergies | 8.3 | 0.088 | 12.0 | 0.049 | 6.7 |
Rheumatoid arthritis | 0.8 | 0.430 | 1.5 | 0.34 | 0.6 |
NSAIDs | 7.7 | 0.142 | 10.8 | <0.001 | 2.2 |
Non-NSAIDs | 9.7 | 0.122 | 13.3 | <0.001 | 3.3 |
Steroids | 5.9 | 0.052 | 9.8 | 0.965 | 9.9 |
ASA treatment | 21.8 | 0.002 | 13.7 | 0.001 | 24.7 |
Antidepressants | 29.6 | 0.511 | 31.7 | <0.001 | 17.1 |
Neuroleptics | 2.2 | 0.943 | 2.1 | 0.650 | 2.7 |
Vitamin B12 supplements | 12.6 | 0.476 | 11.0 | 0.038 | 17.1 |
Treatment for thyroid conditions | 8.1 | 0.081 | 11.8 | 0.013 | 5.4 |
Results are proportions, indicated as percentages, unless indicated otherwise. AD and MCI group means and proportions were compared to SCI. p values correspond to χ2 tests or binary logistic regression, as appropriate. TIA = Transient ischemic attack; NSAIDs = non-steroidal anti-inflammatory drugs; ASA = acetylsalicylic acid.